Cellebrite DI (CLBT) Receivables - Other (2020 - 2026)

Cellebrite DI has reported Receivables - Other for 7 years, with the latest figure at $57.1 million in Q2 2026.

• On a quarterly basis, Receivables - Other fell 22.41% year-over-year to $57.1 million in Q2 2026; TTM through Jun 2026 was $57.1 million, a 22.41% decrease from a year earlier, with the FY2025 full-year figure at $78.6 million, down 3.41% from the prior year.
• Receivables - Other was $57.1 million for Q2 2026 at Cellebrite DI, up from $32.4 million in the prior quarter.
• The five-year high for Receivables - Other was $97.8 million in Q2 2024, with the low at -$24.1 million in Q3 2022.
• Average Receivables - Other over 5 years is $33.8 million, with a median of $15.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other slumped 558.07% in 2022, then surged 3481.68% in 2024.
• Over 5 years, Receivables - Other stood at -$12.9 million in 2022, then soared by 117.63% to $2.3 million in 2023, then soared by 3481.68% to $81.3 million in 2024, then declined by 3.41% to $78.6 million in 2025, then retreated by 27.27% to $57.1 million in 2026.
• The last three Receivables - Other figures came in at $57.1 million (Q2 2026), $32.4 million (Q1 2026), and $78.6 million (Q4 2025), per Business Quant data.